15 March 2024, 06:28 PM
Altraz is important in promoting breast cancer recovery, particularly in postmenopausal women with hormone receptor-positive tumors. As an aromatase inhibitor, Altraz effectively inhibits the production of estrogen, a hormone that promotes the growth of hormone receptor-positive breast tumors. Altraz reduces estrogen levels in the body, which slows tumor progression, reduces the risk of recurrence, and improves overall survival. This medicine is often used as adjuvant therapy after surgery or as the first line of treatment for advanced breast cancer. While Altraz may cause side effects such as hot flashes and joint discomfort, its shown efficacy in improving outcomes highlights its significance in breast cancer recovery, providing patients with a useful tool in their journey to remission and long-term health.